The Week Ahead: Nike Earnings, FDA Debates E-Cig Industry, SurveyMonkey IPOs
Below is a list of notable corporate events for the week beginning Sept. 24. Note, thi.....»»
The Week Ahead: Nike Earnings, FDA Debates E-Cig Industry, SurveyMonkey IPOs
Below is a list of notable corporate events for the week beginning Sept. 24. Note, thi.....»»
The Week Ahead: Senate Weighs Sprint-T-Mobile Merger, Nike Earnings And A Slew Of IPOs
Below is a list of notable corporate events for the week beginning June 25. Note, this list is not comprehensive and all dates are subject to change. All times are ET. Monday Notable Earnings Latest Rati.....»»
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
Biotech stocks reversed course in the week ended April 16, with the sector re.....»»
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vac.....»»
Here"s How Large Nike Option Traders Are Positioning Ahead Of Earnings
Nike Corporation (NYSE: NKE) shares are trading higher this week and are now up 33.5% year.....»»
Not Over Yet: Twists And Turns Still Ahead Including Nike Earnings, Quadruple Witching
A lot of holiday packages got wrapped up last week, including a Phase One trade deal, a Fed meeting, and the UK election, but the week ahead still has a few bows left to tie. We’re in.....»»
The Week Ahead In Cannabis: Earnings, Store Openings And More
The following five days will be very busy for the cannabis industry as no less than 20 companies are set to report results for the last.....»»
The Week Ahead In Cannabis: More Earnings And The Cannabis Capital Conference
This week for the cannabis industry will be a busy one, as a number of companies are scheduled to post financial results for the last quarter. Here's a brief overview of the companies to be keeping an eye on. O.....»»
The Week Ahead In Cannabis: More Earnings And The Cannabis Capital Conference
This week for the cannabis industry will be a busy one, as a number of companies are scheduled to post financial results for the last quarter. Here's a brief overview of the companies to be keeping an eye on. read more.....»»
The Week Ahead In Cannabis: Earnings, CannTrust Update And More
Earnings reports, M&A deal updates and a potential update regarding CannTrust Holdings Inc (NYSE: CTST) -- Here's what scheduled to take place this week in the cannabis industry. read more.....»»
Nike, Micron, Walgreens, FedEx, and More Major Earnings Coming This Week
We have included the consensus earnings estimates, as well as the stock price and trading history. Be advised that the earnings and revenue estimates may change ahead of the formal reports, and some........»»
The Week Ahead In Cannabis: Canopy Earnings, CannaCon In Detroit And More
Last week was quite eventful for the cannabis industry, with Colorado reaching $1.0 billion in sales and Kroger Co (NYSE: KR) announcing plans to start carrying CBD products. Here’s what you should keep an e.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Biotech stocks staged a recovery this week after being in the red in the previous two weeks. AbbVie Inc (NYSE: ABBV)'s psoriasis drug Skyrizi received FDA nod. The week also saw the release of strong quarterly earnings by big European pharma gian.....»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks are on track to extend their losses, bucking the positive broader market sentiment. The week saw Achaogen Inc (NASDAQ: AKAO) filing for Chapter 11 bankruptcy and negative clinical readouts .....»»
Cramer"s game plan: Overvalued IPOs can dim a positive earnings season
Jim Cramer breaks down the week ahead in earnings and stock trading......»»
Cramer: Overvalued IPOs can dim a positive earnings season
Jim Cramer breaks down the week ahead in earnuings and stock trading......»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks witnessed a slowdown in momentum last week, which was a relatively slow one in terms of news flow. Amgen, Inc. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Biotech stocks came under pressure last week despite two FDA approvals coming through. read more.....»»
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Biotech stocks came under pressure last week despite two FDA approvals coming through. The FDA approved SAGE Therapeutics Inc (NASDAQ:.....»»